Viracta Therapeutics, Inc. (VIRX)
OTCMKTS · Delayed Price · Currency is USD
0.0098
+0.0002 (1.88%)
Inactive · Last trade price on Jul 16, 2025

Viracta Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 20192019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2019
Net Income
-43.29-51.06-49.2-114.76-19.02-13.56
Upgrade
Depreciation & Amortization
0.440.490.210.180.030
Upgrade
Other Amortization
-----1.61
Upgrade
Asset Writedown & Restructuring Costs
---88.48--0.01
Upgrade
Loss (Gain) From Sale of Investments
-1.16-2.05-0.63---
Upgrade
Stock-Based Compensation
6.257.6513.555.540.350.63
Upgrade
Other Operating Activities
---0.030.01-0.04
Upgrade
Change in Accounts Payable
-0.55-0.1-0.360.920.970.9
Upgrade
Change in Other Net Operating Assets
3.515.180.970.761.60.09
Upgrade
Operating Cash Flow
-34.8-39.89-35.46-18.85-16.05-10.38
Upgrade
Capital Expenditures
--0.14-0.05-0.25-0.06-
Upgrade
Cash Acquisitions
---17.14--
Upgrade
Sale (Purchase) of Intangibles
----4--
Upgrade
Investment in Securities
43.3315.14-53.82---
Upgrade
Investing Cash Flow
43.3315-53.8712.89-0.06-
Upgrade
Long-Term Debt Issued
--19.99-5.26-
Upgrade
Total Debt Issued
--19.99-5.26-
Upgrade
Long-Term Debt Repaid
----0.23--
Upgrade
Net Debt Issued (Repaid)
-8.6-19.99-0.235.26-
Upgrade
Issuance of Common Stock
0.340.442.5662.660.850.01
Upgrade
Financing Cash Flow
-8.260.4422.5462.4344.9824.58
Upgrade
Net Cash Flow
0.27-24.46-66.7856.4728.8714.2
Upgrade
Free Cash Flow
-34.8-40.03-35.5-19.1-16.11-10.38
Upgrade
Free Cash Flow Per Share
-0.89-1.04-0.94-0.60-49.61-4.41
Upgrade
Cash Interest Paid
3.133.070.450.340.12-
Upgrade
Levered Free Cash Flow
-23.36-21.79-17.78-21.23-8.96-5.34
Upgrade
Unlevered Free Cash Flow
-21.37-19.47-17.42-20.92-8.82-5.91
Upgrade
Change in Net Working Capital
-1.45-4.21-0.49-2.18-2.61-0.99
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.